Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hassan Lakkis

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|September 17, 2013
Sample size calculation for comparing two negative binomial ratesHaiyuan Zhu, Hassan Lakkis
Statistics in Medicine|June 6, 2014
Authors' reply to comments on 'Sample size calculation for comparing two negative binomial rates'Haiyuan Zhu, Hassan Lakkis
Pharmaceutical Statistics|December 12, 2023
Analysis of two binomial proportions in noninferiority confirmatory trialsHassan Lakkis, Andrew Lakkis
CNS Spectrums|September 29, 2025
Efficacy of Lumateperone in depression associated with bipolar II disorder: a pooled analysis of late-phase clinical trialsSuresh Durgam, Hassan Lakkis, Susan G Kozauer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 25, 2026
Long-term adjunctive lumateperone 42 mg treatment in major depressive disorder: Results from a 6-month open-label extension studySuresh Durgam, Willie R Earley, Susan G Kozauer, et al.
Neuropsychiatric Disease and Treatment|June 25, 2026
Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled TrialMichael E Thase, Willie R Earley, Susan G Kozauer, et al.
Human Vaccines|January 6, 2007
large-scale serologic testing program to assess the immunogenicity of inactivated hepatitis a vaccine (VAQTA) in prefilled syringes following product recall in GermanyGundula Jäger, Barbara Kuter, Hartmut Campe, et al.
The Pediatric Infectious Disease Journal|July 29, 2009
Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothersRichard Doherty, Suzanne Garland, Martin Wright, et al.
The Journal of Clinical Psychiatry|August 28, 2025
Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 TrialSuresh Durgam, Willie R Earley, Susan G Kozauer, et al.
COPD|February 11, 2012
Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I)Edward M Kerwin, Anthony D D'Urzo, Arthur F Gelb, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|September 17, 2013
Sample size calculation for comparing two negative binomial ratesHaiyuan Zhu, Hassan Lakkis
Statistics in Medicine|June 6, 2014
Authors' reply to comments on 'Sample size calculation for comparing two negative binomial rates'Haiyuan Zhu, Hassan Lakkis
Pharmaceutical Statistics|December 12, 2023
Analysis of two binomial proportions in noninferiority confirmatory trialsHassan Lakkis, Andrew Lakkis
CNS Spectrums|September 29, 2025
Efficacy of Lumateperone in depression associated with bipolar II disorder: a pooled analysis of late-phase clinical trialsSuresh Durgam, Hassan Lakkis, Susan G Kozauer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 25, 2026
Long-term adjunctive lumateperone 42 mg treatment in major depressive disorder: Results from a 6-month open-label extension studySuresh Durgam, Willie R Earley, Susan G Kozauer, et al.
Neuropsychiatric Disease and Treatment|June 25, 2026
Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled TrialMichael E Thase, Willie R Earley, Susan G Kozauer, et al.
Human Vaccines|January 6, 2007
large-scale serologic testing program to assess the immunogenicity of inactivated hepatitis a vaccine (VAQTA) in prefilled syringes following product recall in GermanyGundula Jäger, Barbara Kuter, Hartmut Campe, et al.
The Pediatric Infectious Disease Journal|July 29, 2009
Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothersRichard Doherty, Suzanne Garland, Martin Wright, et al.
The Journal of Clinical Psychiatry|August 28, 2025
Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 TrialSuresh Durgam, Willie R Earley, Susan G Kozauer, et al.
COPD|February 11, 2012
Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I)Edward M Kerwin, Anthony D D'Urzo, Arthur F Gelb, et al.
Pageof 2